prikaz prve stranice dokumenta Thrombosis of bare metal and patent drug eluting stent in patient operated for colorectal carcinoma: the utility of new guidelines in patients with malignancy
  Preuzmi
PDF 5.41 MB
Znanstveni rad - Prikaz slučaja
Thrombosis of bare metal and patent drug eluting stent in patient operated for colorectal carcinoma: the utility of new guidelines in patients with malignancy
International Journal of Cardiology, 142 (2010), 2; e17-e19. https://doi.org/10.1016/j.ijcard.2008.11.165
Šikić, Jozica; Starčević, Boris; Ivković, Mira; Sičaja, Mario; Manojlović, Spomenka

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Šikić, J., Starčević, B., Ivković, M., Sičaja, M. i Manojlović, S. (2010). Thrombosis of bare metal and patent drug eluting stent in patient operated for colorectal carcinoma: the utility of new guidelines in patients with malignancy. International Journal of Cardiology, 142. (2), e17-e19. doi: 10.1016/j.ijcard.2008.11.165

Šikić, Jozica, et al. "Thrombosis of bare metal and patent drug eluting stent in patient operated for colorectal carcinoma: the utility of new guidelines in patients with malignancy." International Journal of Cardiology, vol. 142, br. 2, 2010, str. e17-e19. https://doi.org/10.1016/j.ijcard.2008.11.165

Šikić, Jozica, Boris Starčević, Mira Ivković, Mario Sičaja i Spomenka Manojlović. "Thrombosis of bare metal and patent drug eluting stent in patient operated for colorectal carcinoma: the utility of new guidelines in patients with malignancy." International Journal of Cardiology 142, br. 2 (2010): e17-e19. https://doi.org/10.1016/j.ijcard.2008.11.165

Šikić, J., et al. (2010) 'Thrombosis of bare metal and patent drug eluting stent in patient operated for colorectal carcinoma: the utility of new guidelines in patients with malignancy', International Journal of Cardiology, 142(2), str. e17-e19. doi: 10.1016/j.ijcard.2008.11.165

Šikić J, Starčević B, Ivković M, Sičaja M, Manojlović S. Thrombosis of bare metal and patent drug eluting stent in patient operated for colorectal carcinoma: the utility of new guidelines in patients with malignancy. International Journal of Cardiology [Internet]. 09.07.2010. [pristupljeno 25.11.2024.];142(2):e17-e19. doi: 10.1016/j.ijcard.2008.11.165

J. Šikić, B. Starčević, M. Ivković, M. Sičaja i S. Manojlović, "Thrombosis of bare metal and patent drug eluting stent in patient operated for colorectal carcinoma: the utility of new guidelines in patients with malignancy", International Journal of Cardiology, vol. 142, br. 2, str. e17-e19, Srpanj 2010. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:314558. [Citirano: 25.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:314558
Podaci o radu
Naslov (engleski)Thrombosis of bare metal and patent drug eluting stent in patient operated for colorectal carcinoma: the utility of new guidelines in patients with malignancy
AutorJozica Šikić
AutorBoris Starčević
AutorMira Ivković
AutorMario Sičaja
AutorSpomenka Manojlović
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Percutaneous coronary intervention with stent placement is widely used to achieve revascularization of the myocardium, especially in acute coronary syndrome. There is increasing number of reports published concerning stent thrombosis both in bare metal stents as in drug eluting stents. According to the newest ACC/AHA/SCAI 2007th guidelines, bare-metal stent or balloon angioplasty is recommended as an optimal solution if surgery is to be performed in 6-12 months time after stent placement. We present a case of a 56-year-old male with colon carcinoma who suffered from post-operational myocardial infarction due to bare metal stent thrombosis, while the drug eluting stent remained patent. Currently, in our opinion, high level evidence is lacking in the literature in support for recommendations published in current ACC, AHA and SCAI 2007th guidelines regarding the choice of stent, antiaggregation and anticoagulation therapy. This case, together with others previously published suggests a need for development of an applicable strategy for selection and treatment of patients with increased perioperative risk of in-stent thrombosis in order to ensure optimal medical treatment.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Prikaz slučaja
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaInternational Journal of Cardiology
Brojčani podacivol. 142, br. 2, str. e17-e19
p-ISSN0167-5273
DOIhttps://doi.org/10.1016/j.ijcard.2008.11.165
URN:NBNurn:nbn:hr:105:314558
Datum objave publikacije2010-07-09
URL dokumentahttps://doi.org/10.1016/j.ijcard.2008.11.165
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 11:11:20